New Mexico is currently home to 422 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Albuquerque, Santa Fe, Las Cruces and Farmington. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
NCT04888117
Recruiting
The study aims to evaluate the short-term clinical outcomes after complex robotic-assisted and laparoscopic cholecystectomies.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
05/26/2023
Locations: Lovelace Medical Group, Albuquerque, New Mexico
Conditions: Laparoscopic Cholecystectomy, Robotic-assisted Cholecystectomy
Register for Updates
Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
NCT05890768
Recruiting
This study will examine the differential relationships between antipsychotic efficacy and changes in dopaminergic and glutamatergic brain metabolism in lumateperone and risperidone treated early psychosis patients. Baseline glutamate and dopamine brain scans, and symptom severity measures will be collected, followed by repeated measures at 6 weeks. Half of the early psychosis patients will be treated with lumateperone, half with risperidone. Healthy control subejcts will also be examined once.
Gender:
All
Ages:
Between 18 years and 40 years
Trial Updated:
05/25/2023
Locations: University of New Mexico, Albuquerque, New Mexico
Conditions: Psychosis
Register for Updates
Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)
NCT05757544
Recruiting
This study is designed to optimize the dosing regimen and evaluate the preliminary safety and efficacy of Intravenous (IV) ganaxolone as adjuvant therapy for participants with ESE receiving initial IV antiepileptic drug (AED) according to currently practiced standard of care (SOC). The study will be composed of 2 phases: an initial, open-label, dose optimization phase followed by IV ganaxolone versus placebo double-blind phase.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/19/2023
Locations: Marinus Research Site, Albuquerque, New Mexico
Conditions: Status Epilepticus
Register for Updates
Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers
NCT05087758
Recruiting
In this study, a novel placental membrane product Matrion™ (LifeNet Health, Inc., Virginia Beach, VA) will be used as a treatment for subjects with diabetic foot ulcers. Matrion is composed of placental membrane derived from donated human birth tissue containing both the innermost amniotic layer and the outermost chorionic layer, inclusive of the trophoblast layer. Matrion is minimally processed and disinfected using a proprietary decellularization technology and terminally sterilized that safel... Read More
Gender:
All
Ages:
Between 21 years and 80 years
Trial Updated:
05/19/2023
Locations: Albuquerque Associated Podiatrists, Albuquerque, New Mexico
Conditions: Diabetic Foot, Lower Extremity Wound
Register for Updates
Social Media Navigation Aid Kits for Urinary Incontinence
NCT05858125
Recruiting
This study aims to compare the effectiveness of a Urogynecology Social Media Navigation Aid Kit (SNAK) and routine counseling in the treatment of women with newly diagnosed urinary incontinence. The study will conduct a randomized controlled trial on treatment-naïve patients seeking care for urinary incontinence. The research will have five aims: evaluate the impact of SNAK on patients' self-efficacy in managing urinary incontinence symptoms compare patient satisfaction with urinary incontinenc... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/18/2023
Locations: University of New Mexico, Albuquerque, New Mexico
Conditions: Urinary Incontinence, Stress Incontinence, Female, Urge Incontinence
Register for Updates
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
NCT04567550
Recruiting
RGX-314 is being developed as a novel, potential one-time gene therapy treatment for the treatment of diabetic retinopathy, a chronic and progressive complication of diabetes mellitus. Diabetic retinopathy (DR) is a sight-threatening disease characterized in the early stages by neuronal and vascular dysfunction in the retina, and later by neovascularization that leads to further deterioration of functional vision. Despite the availability of current treatments, diabetic retinopathy remains the l... Read More
Gender:
All
Ages:
Between 25 years and 89 years
Trial Updated:
05/18/2023
Locations: Vision Research Center Eye Associates of New Mexico, Albuquerque, New Mexico
Conditions: Diabetic Retinopathy (DR)
Register for Updates
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT04514653
Recruiting
RGX-314 is being developed as a potential novel one-time gene therapy treatment for the treatment of neovascular (wet) age related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-VEGF therapies have significantly changed the landscape for tre... Read More
Gender:
All
Ages:
Between 50 years and 89 years
Trial Updated:
05/18/2023
Locations: Albuquerque Location, Albuquerque, New Mexico
Conditions: Neovascular Age-Related Macular Degeneration (nAMD)
Register for Updates
Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial
NCT05571917
Recruiting
This study is a multisite randomized clinical trial of a treatment designed to reduce pain interference while simultaneously addressing relapse prevention among individuals who have co-occurring chronic pain and Opioid Use Disorder (OUD). This study will recruit approximately 160 individuals who are currently being treated in clinics specializing in the physician management of OUD. To increase generalizability of study findings and increase internal validity of the physician management component... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/09/2023
Locations: University of New Mexico, Albuquerque, New Mexico
Conditions: Opioid Use Disorder, Chronic Pain
Register for Updates
Pain and Opioids: Integrated Treatment In Veterans
NCT04648228
Recruiting
This trial will recruit veterans with chronic pain (N = 160) who are prescribed buprenorphine for the treatment of opioid use disorder (OUD). We seek to: (1) examine the efficacy of an integrated treatment to reduce pain interference and substance misuse (Acceptance and Commitment Therapy and Mindfulness-Based Relapse Prevention [ACT + MBRP]) compared to an education control (EC) consisting of a protocol-based series of education sessions concerning chronic pain, opioids, and buprenorphine use a... Read More
Gender:
All
Ages:
Between 21 years and 75 years
Trial Updated:
05/09/2023
Locations: New Mexico VA Healthcare System, Albuquerque, New Mexico
Conditions: Chronic Pain, Opioid-use Disorder, Opioids; Harmful Use
Register for Updates
Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment
NCT05489068
Recruiting
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivationa... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/08/2023
Locations: Turning Point Recovery Center, Albuquerque, New Mexico
Conditions: Substance-Related Disorders, Treatment Adherence
Register for Updates
SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
NCT04155034
Recruiting
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/02/2023
Locations: University of New Mexico Cancer Center, Albuquerque, New Mexico
Conditions: Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
Register for Updates
Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
NCT04432883
Recruiting
62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-u... Read More
Gender:
All
Ages:
Between 25 years and 85 years
Trial Updated:
05/01/2023
Locations: University of New Mexico Center for Brain Recovery and Repair, Albuquerque, New Mexico
Conditions: Stroke, Aphasia
Register for Updates